Clinical review and decision support
Defined pathways for selected cases, second opinions, progression reviews and multidisciplinary discussion, based on the information supplied and the agreed scope.
Learn more
Institutional oncology support
Oncology capability, scoped to your institution.
Hospitals and nursing homes have different patient populations, infrastructure and specialist capabilities. Some need additional oncology review, molecular interpretation, multidisciplinary discussion or a defined route to day care and infusion without building every component in-house.
Where KPCIRC may support an institution
Precision oncology and molecular interpretation
POAS provides structured interpretation of existing NGS and molecular reports, including evidence strength, therapeutic context, trial opportunities, access considerations and limitations.
Learn more
Molecular Tumour Board collaboration
The institution and KPCIRC agree how cases are submitted, which specialists participate, how findings are documented and who communicates the output to the treating clinician.
Learn more
Oncology day care and infusion
Where a suitable facility, qualified personnel and approved protocols exist, arrangements may include chemotherapy, immunotherapy, biologic sessions, supportive infusions and selected related procedures, confirmed site by site.
Learn moreAlso available to discuss
Oncology and haemato-oncology
Defined service models based on clinical requirements, never advertised until clinicians, facilities and protocols are confirmed.
Complementary clinical services
Hereditary assessment, genetic counselling, pharmacogenomics, screening and risk assessment, and clinical navigation.
High-risk observation
Protocol-led observation and high-acuity sessions where specialist leadership and readiness are verified.
Chair and session planning
For institutions planning day-care capacity, KPCIRC uses indicative session bands from its service brochure.
| Session band | Indicative duration | Planning purpose | Operations note |
|---|---|---|---|
| Short session | Up to 2 hours | Selected infusions or treatment sessions with shorter administration and protocol-defined observation. | Confirm chair allocation, staffing, monitoring and discharge criteria for the prescribed therapy. |
| Standard session | 2–4 hours | Planned outpatient treatment with pre-assessment, prescribed administration and observation as required. | Actual duration depends on the medicine, regimen and required monitoring. |
| Extended session | 4–6 hours | Regimens or supportive treatment that need longer administration or observation. | Confirm capacity and whether the site can safely provide the full session. |
| High-acuity or desensitisation | More than 6 hours | Selected complex or desensitisation pathways where a specialist protocol and suitable facility capability exist. | Offered only after staff, emergency readiness, equipment and protocols are verified at the named site. |
These are scheduling categories for planning. They are not a clinical risk score, a guarantee of chair availability or a prediction of an individual’s treatment duration. The prescription, product label, protocol, patient condition and required observation determine the actual schedule.
Partnership principles
- The institution’s regulatory obligations and local operating requirements remain applicable.
- No treatment service starts until required personnel, facilities, protocols and responsibilities are in place.
- Medicines and treatment administration follow the institution’s clinical policies and applicable requirements.
- Patient-level clinical decisions remain with the responsible clinician under the agreed care model.
- Commercial terms, billing, insurance, documentation and liability are agreed before launch.
Short explainers, in production
- Support for hospitalsAbout 60–75 seconds
- Day care and the infusion-chair modelAbout 60–75 seconds
Illustrative institutional scenarios
Educational composite scenarios that explain possible workflows. They are not real KPCIRC patients, testimonials or outcomes.